Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. The firm's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.
Dr. Frank Laukien est le Chairman of the Board de Bruker Corp, il a rejoint l'entreprise depuis 1991.
Quelle est la performance du prix de l'action BRKRP ?
Le prix actuel de BRKRP est de $0, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Bruker Corp ?
Bruker Corp appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quel est la capitalisation boursière de Bruker Corp ?
La capitalisation boursière actuelle de Bruker Corp est de $65.9B
Est-ce que Bruker Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 17 analystes ont établi des notations d'analystes pour Bruker Corp, y compris 6 achat fort, 6 achat, 8 maintien, 1 vente et 6 vente forte